How Viral Proteases Trigger Lytic Cell Death for Universal mRNA Therapy
Highlights • Engineered GSDMs are tailored as VIDAs to sense viral protease • VIDA is inert without infection and has potent antiviral effects in vitro and in vivo • VIDA elicits a “kill-and-alert” antiviral immune response in mice • AI-driven accelerated evolution generates safer and more potent VIDAs